A Study Comparing ATB200/AT2221 With Alglucosidase Alfa/Placebo in Adult Subjects With Late-onset Pompe Disease

Clinical trial NCT03729362 · COMPLETED

Trial details

NCT number: NCT03729362
Sponsor: Amicus Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pompe Disease (Late-onset)

Start date: 2018-12-04
Primary completion: 2020-12-15
Enrollment: 125

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.